Literature DB >> 36157290

Explore the Relationship Between Short-Term Ambient Air Pollution Exposure and Daily Outpatient Visits for Metabolic Related Fatty Liver.

Ming-Wei Wang1, Lixia Sun2, Wen Wen1, Jie Wang3, Chun-Yi Wang1, Jie Ni1, Jing-Jie Jiang1, Zhan-Hui Feng4, Yong-Ran Cheng5.   

Abstract

Background: Many studies have shown that the pollution of fine particles in the air is related to the incidence of chronic diseases. However, research on air pollution and metabolism-associated fatty liver disease (MAFLD) is limited. Objective: The purpose of this study was to explore the relationship between short-term ambient air pollution and daily outpatient visits for metabolic-related fatty liver.
Methods: We used a quasi-Poisson regression generalized additive model to stratify analyses by season, age, and gender.
Results: From January 1, 2017, to August 31, 2019, 10,562 confirmed MAFLD outpatient visits were recorded. A 10 µg/m3 increase of fine particular matter (PM10and PM2.5) and NO2 concentrations corresponding with percent change were 0.82 (95% confidence interval [CI], 0.49-1.15), 0.57 (95% CI, 0.18-0.98), and 0.86 (95% CI, 0.59-1.13) elevation in MAFLD outpatient visits. In terms of season, the impact estimates of NO2 and PM2.5% change were 3.55 (95% CI, 1.23-5.87) and 1.12 (95% CI, 0.78-1.46) in the hot season and transition season, respectively. Compared with the warm season, the impact estimates of PM10were more significant in the cool season: 2.88 (95% CI, 0.66-5.10). NO2 has the greatest effect in the transition season, whereas PM10 has the greatest highest effect in the cool and hot seasons. Compared with other pollutants, PM2.5 has the greatest impact in the age stratification, which percent change are 2.69 (95% CI, 0.77-5.61) and 2.88 (95% CI, 0.37-6.40) respectively. The impact values of PM2.5 in male and female percent change were 3.60 (95% CI, 0.63-6.57) and 1.65 (95% CI, 1.05-2.25), respectively.
Conclusion: This study shows that the air pollutants are related to the number of outpatient visits for MAFLD. The effects of different air pollutants on MAFLD outpatient visits were different by season, ages, and gender.
© 2022 Wang et al.

Entities:  

Keywords:  air pollutants; generalized additive model; metabolism-associated fatty liver disease

Year:  2022        PMID: 36157290      PMCID: PMC9505349          DOI: 10.2147/RMHP.S364270

Source DB:  PubMed          Journal:  Risk Manag Healthc Policy        ISSN: 1179-1594


  35 in total

1.  Fine Particulate Air Pollution and Daily Mortality. A Nationwide Analysis in 272 Chinese Cities.

Authors:  Renjie Chen; Peng Yin; Xia Meng; Cong Liu; Lijun Wang; Xiaohui Xu; Jennifer A Ross; Lap A Tse; Zhuohui Zhao; Haidong Kan; Maigeng Zhou
Journal:  Am J Respir Crit Care Med       Date:  2017-07-01       Impact factor: 21.405

2.  Attributable risk of hospital admissions for overall and specific mental disorders due to particulate matter pollution: A time-series study in Chengdu, China.

Authors:  Hang Qiu; Xiaojuan Zhu; Liya Wang; Jingping Pan; Xiaorong Pu; Xiaoxi Zeng; Li Zhang; Zhao Peng; Li Zhou
Journal:  Environ Res       Date:  2018-12-12       Impact factor: 6.498

Review 3.  Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.

Authors:  Shiv K Sarin; Manoj Kumar; Mohammed Eslam; Jacob George; Mamun Al Mahtab; Sheikh M Fazle Akbar; Jidong Jia; Qiuju Tian; Rakesh Aggarwal; David H Muljono; Masao Omata; Yoshihiko Ooka; Kwang-Hyub Han; Hye Won Lee; Wasim Jafri; Amna S Butt; Chern H Chong; Seng G Lim; Raoh-Fang Pwu; Ding-Shinn Chen
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-12-15

4.  GBD 2010: design, definitions, and metrics.

Authors:  Christopher J L Murray; Majid Ezzati; Abraham D Flaxman; Stephen Lim; Rafael Lozano; Catherine Michaud; Mohsen Naghavi; Joshua A Salomon; Kenji Shibuya; Theo Vos; Daniel Wikler; Alan D Lopez
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

Review 5.  Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.

Authors:  Zobair Younossi; Frank Tacke; Marco Arrese; Barjesh Chander Sharma; Ibrahim Mostafa; Elisabetta Bugianesi; Vincent Wai-Sun Wong; Yusuf Yilmaz; Jacob George; Jiangao Fan; Miriam B Vos
Journal:  Hepatology       Date:  2019-06       Impact factor: 17.425

6.  Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis.

Authors:  Jie Li; Biyao Zou; Yee Hui Yeo; Yuemin Feng; Xiaoyu Xie; Dong Hyun Lee; Hideki Fujii; Yuankai Wu; Leslie Y Kam; Fanpu Ji; Xiaohe Li; Nicholas Chien; Mike Wei; Eiichi Ogawa; Changqing Zhao; Xia Wu; Christopher D Stave; Linda Henry; Scott Barnett; Hirokazu Takahashi; Norihiro Furusyo; Yuichiro Eguchi; Yao-Chun Hsu; Teng-Yu Lee; Wanhua Ren; Chengyong Qin; Dae Won Jun; Hidenori Toyoda; Vincent Wai-Sun Wong; Ramsey Cheung; Qiang Zhu; Mindie H Nguyen
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-03-20

7.  Kupffer cell activation by ambient air particulate matter exposure may exacerbate non-alcoholic fatty liver disease.

Authors:  Hui-Hui Tan; M Isabel Fiel; Qinghua Sun; Jinsheng Guo; Ronald E Gordon; Lung-Chi Chen; Scott L Friedman; Joseph A Odin; Jorge Allina
Journal:  J Immunotoxicol       Date:  2009-12       Impact factor: 3.000

8.  Lifestyle and environmental factors associated with inflammation, oxidative stress and insulin resistance in children.

Authors:  Roya Kelishadi; Nourollah Mirghaffari; Parinaz Poursafa; Samuel S Gidding
Journal:  Atherosclerosis       Date:  2008-07-01       Impact factor: 5.162

9.  Season, sex and age as modifiers in the association of psychosis morbidity with air pollutants: A rising problem in a Chinese metropolis.

Authors:  Ling Tong; Kai Li; Qixing Zhou
Journal:  Sci Total Environ       Date:  2015-11-11       Impact factor: 7.963

10.  Outdoor Air Pollution and Pterygium in Korea.

Authors:  Ki Woong Lee; Yoon Hyeong Choi; Sung Ha Hwang; Hae Jung Paik; Mee Kum Kim; Won Ryang Wee; Dong Hyun Kim
Journal:  J Korean Med Sci       Date:  2017-01       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.